Pages that link to "Q40209979"
Jump to navigation
Jump to search
The following pages link to Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J. (Q40209979):
Displaying 50 items.
- PACAP inhibits tumor growth and interferes with clusterin in cervical carcinomas (Q24307847) (← links)
- Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma (Q28474030) (← links)
- NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance (Q28476301) (← links)
- Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma (Q30886810) (← links)
- Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker (Q33427212) (← links)
- The kinase Mirk is a potential therapeutic target in osteosarcoma (Q33521423) (← links)
- Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway (Q33575279) (← links)
- Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells (Q34114810) (← links)
- Identification of host-immune response protein candidates in the sera of human oral squamous cell carcinoma patients (Q34278535) (← links)
- Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma (Q34365891) (← links)
- Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex (Q34913292) (← links)
- Clusterin confers gmcitabine resistance in pancreatic cancer (Q35061171) (← links)
- A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells. (Q35263202) (← links)
- Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells (Q35458425) (← links)
- Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel. (Q35780679) (← links)
- NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function. (Q35851832) (← links)
- Clusterin/Akt Up-Regulation Is Critical for GATA-4 Mediated Cytoprotection of Mesenchymal Stem Cells against Ischemia Injury (Q35952100) (← links)
- Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells (Q35986590) (← links)
- p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines (Q36568079) (← links)
- Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin (Q37089543) (← links)
- Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines (Q37097022) (← links)
- Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas (Q37288916) (← links)
- Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines. (Q37397276) (← links)
- Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells (Q37418683) (← links)
- Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity (Q37624993) (← links)
- Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals (Q37624996) (← links)
- Clusterin and chemoresistance (Q37625188) (← links)
- Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma (Q37636632) (← links)
- Transcription factor NF‑YA promotes a malignant phenotype by upregulating fatty acid synthase expression (Q37707639) (← links)
- Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal (Q38349935) (← links)
- HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells. (Q38827721) (← links)
- Small non-coding RNAs-based bone regulation and targeting therapeutic strategies. (Q39020213) (← links)
- Clusterin as a therapeutic target (Q39039324) (← links)
- Effects of Navelbine and Docetaxel on Gene Expression in Human Lung Cancer Cell Lines (Q39491276) (← links)
- Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer (Q39524455) (← links)
- Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells. (Q39532644) (← links)
- Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway (Q40005641) (← links)
- Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells (Q41996659) (← links)
- miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo (Q42322707) (← links)
- LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. (Q42654010) (← links)
- Establishment and Characterization of New Canine and Feline Osteosarcoma Primary Cell Lines (Q46540533) (← links)
- Expression and significance of secreted protein acidic and rich in cysteine in human osteosarcoma (Q47350176) (← links)
- Clusterin expression inversely correlates with chemosensitivity and predicts poor survival in patients with locally advanced cervical cancer treated with cisplatin-based neoadjuvant chemotherapy and radical hysterectomy. (Q51790230) (← links)
- Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1. (Q52645998) (← links)
- Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights. (Q52673808) (← links)
- KH OS R1 (Q54899846) (← links)
- KH OS R2 (Q54899847) (← links)
- KH OS R3 (Q54899848) (← links)
- U-2 OS R1 (Q54973538) (← links)
- U-2 OS R2 (Q54973539) (← links)